Showing 3,061 - 3,080 results of 9,864 for search '"drug"', query time: 0.08s Refine Results
  1. 3061

    A Case Report of Subacute Combined Spinal Cord Degeneration Caused by Nitrous Oxide (‘Laughing Gas’) Abuse by J. Guk, J. Valančienė, A. Klimašauskienė

    Published 2024-02-01
    “…Although nitrous oxide (N2O) has long been used as an anesthetic, it’s use as a recreational drug has recently increased. As N2O abuse is associated with a number of adverse health effects, it has become a significant public health issue. …”
    Get full text
    Article
  2. 3062

    Galangin-Loaded Gold Nanoparticles: Molecular Mechanisms of Antiangiogenesis Properties in Breast Cancer by Malik H. Qaddoori, Hanady S. Al-Shmgani

    Published 2023-01-01
    “…Angiogenesis is important for tissue during normal physiological processes as well as in a number of diseases, including cancer. Drug resistance is one of the largest difficulties to antiangiogenesis therapy. …”
    Get full text
    Article
  3. 3063

    Bioinorganic Nanoparticles for the Remediation of Environmental Pollution: Critical Appraisal and Potential Avenues by Md. Mominur Rahman, Limon Ahmed, Fazilatunnesa Anika, Anha Akter Riya, Sumaiya Khatun Kali, Abdur Rauf, Rohit Sharma

    Published 2023-01-01
    “…Modern research advances focus more on polymer-based nanoparticles, which are frequently used in drug design, drug delivery systems, environmental remediation, power storage, transformations, and other fields. …”
    Get full text
    Article
  4. 3064

    Interactive ethics teaching for students of chemistry by Hay Alastair W.M.

    Published 2024-11-01
    “…In the first exercise chemists are invited to make a drug using a simple chemical process and answer a range of questions. …”
    Get full text
    Article
  5. 3065

    Structure-Function of Falcipains: Malarial Cysteine Proteases by Kailash C. Pandey, Rajnikant Dixit

    Published 2012-01-01
    “…Overall, the complexes of falcipain-2 and falcipain-3 with small and macromolecular inhibitors provide structural insight to facilitate the design or modification of effective drug treatment against malaria. Drug development targeting falcipains should be aided by a strong foundation of biochemical and structural studies.…”
    Get full text
    Article
  6. 3066

    Posttranslational Modifications and the Immunogenicity of Biotherapeutics by Roy Jefferis

    Published 2016-01-01
    “…These considerations may frustrate the possibility of ameliorating the immunogenicity of mAbs by rigorous exclusion of aggregates from drug product. Alternate strategies for inducing immunosuppression or tolerance are discussed.…”
    Get full text
    Article
  7. 3067

    Long Term Safety of Infliximab by Thomas F Schaible

    Published 2000-01-01
    “…While low titres of autoantibodies developed in less than 10% of patients, drug-induced lupus was seen in less than 1%, with these cases resolving upon discontinuation of the drug. …”
    Get full text
    Article
  8. 3068
  9. 3069

    HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART by Caron A. Jacobson, Jeremy S. Abramson

    Published 2012-01-01
    “…Despite these significant advances, HIV-HL patients remain at increased risk for treatment-related toxicities and drug-drug interactions which require careful attention and supportive care to insure the safe administration of therapy. …”
    Get full text
    Article
  10. 3070

    Ankle edema after administration of selective serotonin reuptake inhibitors by Konstantinos Kontoangelos, Marina Ecomomou, Charalambos Papageorgiou

    Published 2018-06-01
    “…Clinical manifestations of drug-induced skin reactions include a wide range of symptoms, from mild drug-induced exanthemas to dangerous and life-threatening generalized systematic reactions. …”
    Get full text
    Article
  11. 3071

    CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian Guidelines for Management and Treatment of HIV/Hepatitis C Coinfection in Adults by Mark Hull, Marina Klein, Stephen Shafran, Alice Tseng, Pierre Giguère, Pierre Côté, Marc Poliquin, Curtis Cooper, on behalf of The CIHR Canadian HIV Trials Network HIV/Hepatitis C Management and Treatment Guidelines Working Group

    Published 2013-01-01
    “…HIV-HCV management is more complex due to the accelerated progression of liver disease, the timing and nature of antiretroviral and HCV therapy, mental health and addictions management, socioeconomic obstacles and drug-drug interactions between new HCV direct-acting antiviral therapies and antiretroviral regimens.…”
    Get full text
    Article
  12. 3072

    Fungal Infections: Their Diagnosis and Treatment in Transplant Recipients by David H. Van Thiel, Magdalena George, Christopher M. Moore

    Published 2012-01-01
    “…The indications for the use of currently available antifungal agents, their adverse effects, drug interactions, ease of dosing, and applicability in patients with preexisting disease states, and especially in liver transplant recipients, are presented in this paper.…”
    Get full text
    Article
  13. 3073

    Spectrophotometric Studies on the Reaction of Diaveridine with Some Sulfonphthalein Dyes Based on Ion-Pair/Ion-Associate Complexes Formation by A. L. El-Ansary, N. S. Abdel-Kader, A. M. Asran

    Published 2018-01-01
    “…Also, spectrophotometric determination of the drug in pure and pharmaceutical preparations was tested.…”
    Get full text
    Article
  14. 3074

    IMPROVING SOME PARAMETERS OF ANTIBODY RESPONSE IN HORSES BY PROBIOTIC AGENTS AGAINST BACKGROUND USE OF MACROCYCLIC LACTONE ANTHELMINTIC by О. A. Mullagaliyeva, Ye. N. Zakrepina

    Published 2019-06-01
    “…The results demonstrated that helminthic invasion and anthelmintic drug Univerm make depressive effect on some parameters of antibody response in horses. …”
    Get full text
    Article
  15. 3075

    Belzutifan for the treatment of renal cell carcinoma by Xiancheng Wu, David Lazris, Risa Wong, Scott S. Tykodi

    Published 2025-02-01
    “…It is the first FDA-approved drug to target hypoxia-inducible factor 2 alpha (HIF-2α). …”
    Get full text
    Article
  16. 3076

    Spectrophotometric Method for the Determination of Nebivolol Hydrochloride in Bulk and Pharmaceutical Formulations by A. Lakshmana Rao, K. R. Rajeswari, G. G. Sankar

    Published 2010-01-01
    “…Nebivolol hydrochloride is an antihypertensive drug, which shows maximum absorbance at 281 nm with apparent molar absorptivity of 5.37208 × 103 mol-1 cm-1. …”
    Get full text
    Article
  17. 3077

    Metastatic SQSTM1-NTRK1 fused non-small-cell lung cancer treated with larotrectinib and stereotactic radiosurgery resulting in durable complete response: a case report by Colton Betts, Ari Kassardjian, Arya Amini

    Published 2025-02-01
    “…Neurotrophic tropomyosin receptor kinase (NTRK) fusions are a rare oncogenic driver that has been targeted with the tumor-agnostic drug, larotrectinib. There are limited data on the treatment of non-small-cell lung cancer (NSCLC) with larotrectinib because of the rarity of this fusion in this population. …”
    Get full text
    Article
  18. 3078

    Advances in Corticosteroid Therapy for Ocular Inflammation: Loteprednol Etabonate by Timothy L. Comstock, Heleen H. DeCory

    Published 2012-01-01
    “…Retrometabolic drug design has advanced the development of new corticosteroids with improved therapeutic indices. …”
    Get full text
    Article
  19. 3079

    Preparation, Characterization, and Analytical Application of Ramipril Membrane-Based Ion-Selective Electrode by Hassan Arida, Mona Ahmed, Abdallah Ali

    Published 2009-01-01
    “…The fabrication and electrochemical evaluation of two PVC membrane-based Ion-Selective electrodes responsive for ramipril drug have been proposed. The sensitive membranes were prepared using ramipril-phosphomolibdate and ramipril-tetraphenylborate ion-pair complexes as electroactive sensing materials in plasticized PVC support. …”
    Get full text
    Article
  20. 3080

    The Discovery of Novel Experimental Therapies for Inflammatory Arthritis by Charles J. Malemud

    Published 2009-01-01
    “…Conventional and biologic disease-modifying antirheumatic drugs have revolutionized the medical therapy of inflammatory arthritis. …”
    Get full text
    Article